Ariane A. van Loevezijn

Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study

Ariane A. van Loevezijn, Marieke E. M. van der Noordaa, Erik van Werkhoven et al. · Annals of Surgical Oncology · 2020 · 90 citations · Full text

Medicine, Oncology, Radiology +17

Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol

Ariane A. van Loevezijn, Marieke E. M. van der Noordaa, Marcel P. M. Stokkel et al. · Breast Cancer Research and Treatment · 2022 · 75 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Internal Mammary Chain Sentinel Nodes in Early-Stage Breast Cancer Patients: Toward Selective Removal

Ariane A. van Loevezijn, Sanne A. L. Bartels, Frederieke van Duijnhoven et al. · Annals of Surgical Oncology · 2018 · 26 citations

Medicine, Oncology, Breast Oncology +15

Omitting axillary lymph node dissection in breast cancer patients with extensive nodal disease and excellent response to primary systemic therapy using the MARI protocol

Annemiek K. E. van Hemert, Ariane A. van Loevezijn, Marie-Sophie P. D. Baas et al. · The Breast · 2025 · 17 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial

Annemiek K. E. van Hemert, Frederieke van Duijnhoven, Ariane A. van Loevezijn et al. · Annals of Surgical Oncology · 2023 · 12 citations · Full text

Medicine, Oncology, Pathology +17